Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9DBX3

Entry ID Method Resolution Chain Position Source
2CQW NMR - A 16-86 PDB
AF-Q9DBX3-F1 Predicted AlphaFoldDB

54 variants for Q9DBX3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389049279 17 P>L No EVA
rs3389117624 28 S>T No EVA
rs3389113339 38 G>* No EVA
rs3389110004 39 L>P No EVA
rs3389106174 55 D>E No EVA
rs30005620 64 L>S No EVA
rs3389102894 106 D>V No EVA
rs3389080708 114 S>* No EVA
rs3401425060 136 P>T No EVA
rs3389085760 160 E>D No EVA
rs3389073314 166 Y>F No EVA
rs1132036225 199 T>K No EVA
rs3389104844 243 V>M No EVA
rs3389117632 247 R>G No EVA
rs3389080642 263 L>P No EVA
rs3389106973 277 D>E No EVA
rs242246466 280 A>E No EVA
rs3389073247 284 A>G No EVA
rs3389117691 297 E>D No EVA
rs3401392273 305 T>A No EVA
rs252878483 305 T>M No EVA
rs3389073272 308 P>S No EVA
rs3389115408 309 D>E No EVA
rs3389073282 326 T>S No EVA
rs3389085752 333 E>D No EVA
rs3389049373 361 Q>H No EVA
rs3389110013 364 C>R No EVA
rs3389110854 424 P>S No EVA
rs3389080669 428 K>T No EVA
rs3389085815 434 D>Y No EVA
rs3389104889 446 A>V No EVA
rs3412056149 467 E>* No EVA
rs247830180 488 R>K No EVA
rs213711685 532 V>A No EVA
rs3401425099 534 S>N No EVA
rs3401343295 536 T>S No EVA
rs3401331212 552 A>T No EVA
rs3389073332 570 V>I No EVA
rs3389073332 570 V>L No EVA
rs3389108112 592 L>F No EVA
rs3389110885 631 S>C No EVA
rs213504278 673 T>P No EVA
rs227244338 676 V>M No EVA
rs3389100117 685 F>I No EVA
rs3389108047 691 M>I No EVA
rs264788252 696 S>P No EVA
rs3389073315 703 R>W No EVA
rs248365239 710 Q>H No EVA
rs3389085802 711 H>Q No EVA
rs259342810 749 N>D No EVA
rs3389093888 783 V>A No EVA
rs3389110003 784 L>I No EVA
rs3389049288 800 I>N No EVA
rs3389073328 815 M>T No EVA

No associated diseases with Q9DBX3

4 regional properties for Q9DBX3

Type Name Position InterPro Accession
domain Sushi/SCR/CCP domain 720 - 777 IPR000436
domain Somatomedin B domain 25 - 64 IPR001212
domain von Willebrand factor, type D domain 433 - 636 IPR001846
domain AMOP domain 282 - 430 IPR005533

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

2 GO annotations of biological process

Name Definition
negative regulation of cell cycle G1/S phase transition Any signalling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.
negative regulation of cell division Any process that stops, prevents, or reduces the frequency, rate or extent of cell division.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q21874 R09E10.5 Uncharacterized protein R09E10.5 Caenorhabditis elegans PR
P34501 K03H1.5 Uncharacterized protein K03H1.5 Caenorhabditis elegans PR
10 20 30 40 50 60
MKLALLPWIL MLLSTIPGPG FTAGAQGSCS LRCGAQDGLC SCHPTCSGLG TCCEDFLDYC
70 80 90 100 110 120
LEILPSSGSM MGGKDFVVQH LKWTDPTDGV ICRFKESIQT LGYVDDFYQV HCISPLLYES
130 140 150 160 170 180
GYIPFTISMD NGRSFPHAGT WLAAHPYKVS ESEKSQLVNE THWQYYGTSD TRGNLNLTWD
190 200 210 220 230 240
TSALPTPAVT IELWGYEETG KPYSGNWTSK WSYLYPLATN IPNTGFFTFT PKPASPQYQR
250 260 270 280 290 300
WKVGALRISS SRNYPGEKDV RALWTNDHAL AWHLGDDFRA DSVAWARAQC LAWEALEDQL
310 320 330 340 350 360
PNFLTELPDC PCTLAQARAD SGRFFTDYGC DIEHGSVCTY HPGAVHCVRS VQASPRYGSG
370 380 390 400 410 420
QQCCYTAAGT QLLTSDSTSG STPDRGHDWG APPYRTPPRV PGMSHWLYDV ISFYYCCLWA
430 440 450 460 470 480
PECPRYMKRR PSSDCRNYRP PRLASAFGDP HFVTFDGTSF SFSGNGEYVL LETTLSDLRV
490 500 510 520 530 540
QGRAQPGRMP NGTQARGTGL TAVAVQEDNS DVIEVRLAGG SRVLEVLLNQ KVLSFTEQNW
550 560 570 580 590 600
MDLKGMFLSV AAQDKVSIML SSGAGLEVGV QGPFLSVSIL LPEKFLTHTR GLLGTLNNNP
610 620 630 640 650 660
RDDFTLRNGQ VLPLNASAQQ VFQFGADWAV SNTSSLFTYD SWLLVYQFVY GPKHNPNFKP
670 680 690 700 710 720
LFPDETTLSP SQTEDVARLC EGDRFCILDV MSTGSSSVGN ATRIAHQLHQ HRLKSLQPVV
730 740 750 760 770 780
SCGWLPPPAN GHKEGLRYLE GSVVRFSCNN GYSLVGPESS TCQADGKWSM PTPECQPGRS
790 800 810
YTVLLSIIFG GLAIVALISI IYMMLHRRRK SNMTMWSSQP